AR106207A1 - VBI CEPAS AND USES OF THE SAME - Google Patents
VBI CEPAS AND USES OF THE SAMEInfo
- Publication number
- AR106207A1 AR106207A1 ARP160102995A ARP160102995A AR106207A1 AR 106207 A1 AR106207 A1 AR 106207A1 AR P160102995 A ARP160102995 A AR P160102995A AR P160102995 A ARP160102995 A AR P160102995A AR 106207 A1 AR106207 A1 AR 106207A1
- Authority
- AR
- Argentina
- Prior art keywords
- vbi
- seq
- sequence
- identity
- sample
- Prior art date
Links
- 239000000523 sample Substances 0.000 abstract 4
- 230000000295 complement effect Effects 0.000 abstract 3
- 241000711450 Infectious bronchitis virus Species 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- 101150027674 S1 gene Proteins 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 244000144977 poultry Species 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
Reivindicación 1: Un virus de la bronquitis infecciosa (VBI) que comprende un gen S1 que tiene una secuencia de nucleótidos con al menos un 98% de identidad con la SEQ ID Nº 1, o la cadena complementaria de la misma. Reivindicación 9: Un ácido nucleico comprende la SEQ ID Nº 1 o una secuencia que tiene al menos un 98% de identidad con la SEQ ID Nº 1, o la cadena complementaria de la misma. Reivindicación 15: Una vacuna que comprende un VBI de una cualquiera de las reivindicaciones 1 a 7, un ácido nucleico de una cualquiera de las reivindicaciones 9 - 10, un vector de una cualquiera de las reivindicaciones 11 - 12, o un polipéptido de la reivindicación 13 ó 14 y, opcionalmente, un excipiente y/o adyuvante adecuado. Reivindicación 17: Un método para proteger aves de corral contra el virus de la bronquitis infecciosa que comprende administrar una vacuna de la reivindicación 15 a pájaros sensibles. Reivindicación 20: Un método para detectar VBI en una muestra, que comprende poner en contacto la muestra con una sonda o cebador especifico para una secuencia de VBI que comprende la SEQ ID Nº 1 o una secuencia que tiene un 98% de identidad con la SEQ ID Nº 1 o la cadena complementaria de la misma y detectar la presencia de dicha secuencia en la muestra.Claim 1: An infectious bronchitis virus (VBI) comprising an S1 gene that has a nucleotide sequence with at least 98% identity with SEQ ID No. 1, or the complementary chain thereof. Claim 9: A nucleic acid comprises SEQ ID No. 1 or a sequence that has at least 98% identity with SEQ ID No. 1, or the complementary chain thereof. Claim 15: A vaccine comprising a VBI of any one of claims 1 to 7, a nucleic acid of any one of claims 9-10, a vector of any one of claims 11-12, or a polypeptide of claim 13 or 14 and, optionally, a suitable excipient and / or adjuvant. Claim 17: A method of protecting poultry against infectious bronchitis virus comprising administering a vaccine of claim 15 to sensitive birds. Claim 20: A method for detecting VBI in a sample, comprising contacting the sample with a probe or primer specific for a VBI sequence comprising SEQ ID No. 1 or a sequence having a 98% identity with the SEQ ID No. 1 or the complementary chain thereof and detect the presence of said sequence in the sample.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BR102015025152A BR102015025152A8 (en) | 2015-09-30 | 2015-09-30 | infectious bronchitis virus, inactivated infectious bronchitis virus, nucleic acid, vector, polypeptide, vaccine, use of a strain of vbi, method for protecting poultry against infectious bronchitis virus, cell, method for preparing a vaccine, and method for detect vbi in a sample |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR106207A1 true AR106207A1 (en) | 2017-12-20 |
Family
ID=58543698
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP160102995A AR106207A1 (en) | 2015-09-30 | 2016-09-30 | VBI CEPAS AND USES OF THE SAME |
Country Status (3)
| Country | Link |
|---|---|
| AR (1) | AR106207A1 (en) |
| BR (1) | BR102015025152A8 (en) |
| PE (2) | PE20170763A1 (en) |
-
2015
- 2015-09-30 BR BR102015025152A patent/BR102015025152A8/en not_active Application Discontinuation
-
2016
- 2016-09-30 PE PE2016001848A patent/PE20170763A1/en unknown
- 2016-09-30 PE PE2021001672A patent/PE20212213A1/en unknown
- 2016-09-30 AR ARP160102995A patent/AR106207A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR102015025152A2 (en) | 2017-04-04 |
| BR102015025152A8 (en) | 2021-08-10 |
| PE20212213A1 (en) | 2021-11-19 |
| PE20170763A1 (en) | 2017-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112017008082A2 (en) | compositions and methods for detecting an rna virus | |
| CO2017007105A2 (en) | New tilapia viruses | |
| AR100238A1 (en) | METHOD FOR PRODUCING L-AMINO ACIDS IN CORINEBACTERIA THROUGH THE USE OF A GLYCINE SCISION SYSTEM | |
| EA201890999A1 (en) | VACCINE AGAINST VIRUS HERPES VIRUS | |
| BR112018067536A2 (en) | transposon system and methods of use | |
| EA201990717A1 (en) | NEW VACCINE AGAINST PIG INFLUENZA | |
| CU24580B1 (en) | ATTENUATED VECTORS OF INFLUENZA FOR THE PREVENTION AND/OR TREATMENT OF INFECTIOUS DISEASES AND FOR THE TREATMENT OF ONCOLOGICAL DISEASES | |
| AR094725A1 (en) | PARVOVIRUS 5A PORCINO, METHODS OF USE AND VACCINE | |
| CO2017001614A2 (en) | Recombinant vector vaccine for avian adenovirus serotype 9 | |
| MX2015016765A (en) | AIRCRAFT CELLS FOR IMPROVED VIRUS PRODUCTION. | |
| MX2023003934A (en) | Filovirus consensus antigens, nucleic acid constructs and vacciens made therefrom, and methods of using same. | |
| BR112016015812A2 (en) | METHOD TO INCREASE BIOMASS AND LIPID CONTENT IN A MICROORGANISM AND A GENETICALLY MODIFIED MICROORGANISM EXHIBITING ENHANCED AUTOPHAGY | |
| AR102803A1 (en) | REOVIRUS AVIAR VACCINES | |
| AR106207A1 (en) | VBI CEPAS AND USES OF THE SAME | |
| AR091963A1 (en) | PROTEIN INSECTICIDE, GEN THAT CODIFIES AND ITS USES | |
| MX2020007676A (en) | MERKEL CELL POLYOMAVIRUS LARGE AND SMALL T ANTIGENS, NUCLEIC ACID CONSTRUCTS AND VACCINES MADE THEREOF, AND METHODS OF USING THEREOF. | |
| AR105291A1 (en) | METHODS AND SETS OF ELEMENTS FOR THE DETECTION OF THE EARTH | |
| AR102333A1 (en) | EFFICIENT SELECTIVITY OF RECOMBINED PROTEINS | |
| AR091964A1 (en) | PROTEIN INSECTICIDE, GEN THAT CODIFIES AND ITS USES | |
| CO2018000255A2 (en) | Chimeric polypeptide, babesiosis vaccine, detection methods and kit | |
| AR105622A1 (en) | THE OLIGONUCLEOTIDES AND ITS USE | |
| AR105539A1 (en) | IMPROVEMENT OF THE IMMUNE RESPONSE IN AQUATIC SPECIES | |
| CL2020003238A1 (en) | New fish virus | |
| AR101731A1 (en) | DIMMED BOVINE CORONAVIRUS AND RELATED VACCINES | |
| Stolyarchuk et al. | SOME REGULARITIES OF SUMMATION OF FATIGUE DAMAGES UNDER CYCLIC CREEP OF MATERIALS |